//
Nathalie Dhedin
Sebastien Maury
Martine Escoffre-Barbe
Oumedaly Reman
Yves Chalandon
Didier Blaise
Nicole Raus
Veronique Lheritier
Jean-Yves Cahn
Herve Dombret
Norbert Ifrah
Reza Tabrizi
Xavier Thomas
Patrice Chevallier
Stephanie Nguyen
Valerie Coiteux
Mathilde Hunault
Stephane de Botton
Yosr Hichri
Hematology, CHU, Angers, France
Hematology, Hopital Pitie-Salptriere, Paris, France
Centre of Oncology, Geneva University Hospital, Geneva, Switzerland
Service dHematologie, Gustave Roussy Cancer Center, Villejuif, France
Centre Hospitalier Lyon-Sud, Pierre-Benite, France
Hematology, CHU Rennes, Rennes, France
Hematology, Bordeaux, France
Service des Maladies du Sang, Hopital Claude Huriez, Lille, France
Unite Adolescents et Jeunes Adultes, Saint Louis Hospital, Paris, France
Hematology, Hopital Henri Mondor, Creteil Cedex, France
Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France
Hematology, CHU, Angers, France
Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC), Lyon, France
Hematology, CHU, Angers, France
Hematology, University Hospital of Toulouse, Toulouse, France
Hematology, CHUV, Montpellier, France
Coordination, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), Lyon, France
Department of Hematology, Grenoble University Hospital, Grenoble, France
Hospital Saint Antoine, Paris, France
France
Switzerland
N/A
Oncology (ONC)
Acute lymphoblastic leukemia
Breakpoint Cluster Region
Histone-lysine N-methyltransferase 2A
T-cell receptor
Cyclophosphamide
Cyclophosphamide Injection
N/A
N/A
NA
N/A
N/A
Interim